Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
547K
-
Shares change
-
-15.3K
-
Total reported value, excl. options
-
$70.2M
-
Value change
-
-$1.86M
-
Put/Call ratio
-
0.07
-
Number of buys
-
23
-
Number of sells
-
-36
-
Price
-
$128.49
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q1 2019
96 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q1 2019.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 547K shares
.
Largest 10 shareholders include MORGAN STANLEY (56.8K shares), UBS Group AG (56.4K shares), CITADEL ADVISORS LLC (47.1K shares), MURPHY CAPITAL MANAGEMENT INC (40K shares), BANK OF AMERICA CORP /DE/ (29.6K shares), Virtu Financial LLC (21.4K shares), MOGY JOEL R INVESTMENT COUNSEL INC (21.2K shares), Strategic Financial Services, Inc, (15.6K shares), COMMONWEALTH EQUITY SERVICES, LLC (15K shares), and BOSTON RESEARCH & MANAGEMENT INC (15K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.